Pharmacia & Upjohn consumer sales fall 2.1% in 1995 due to lower Motrin IB volume.
This article was originally published in The Tan Sheet
Executive Summary
PHARMACIA & UPJOHN CONSUMER PHARMACEUTICALS 1995 SALES FALL 2.1% to $441.5 mil. worldwide, because of lower Motrin IB sales, the firm said in a Feb. 22 release. The decline in sales for the analgesic was attributed to retail inventory reductions early in the year. The 1995 decline for Motrin IB follows a 12% gain in sales for the brand in 1994.